The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring
Open accessAbstract
Objective: In lupus nephritis, glomerular injury correlates poorly with progression to renal failure. While the tubulointerstitium is also commonly involved, the importance of such involvement is not well defined. Therefore, we developed a simple method to assess the prognostic utility of measuring tubulointerstitial inflammation (TI). Methods: Sixty‐eight systemic lupus erythematosus patients with lupus nephritis were enrolled. Tubulointerstitial lymphocytic infiltrates were quantitated both by anti‐CD45 antibody staining and standard histochemical staining. Followup data were obtained and survival analysis was carried out to determine which histologic features were predictive of subsequent renal failure. Results: By CD45 staining, TI was a common pathologic finding, with 72% of biopsies having moderate or severe involvement. The extent of TI correlated with serum creatinine, but not with double‐stranded DNA antibodies, serum C3, or glomerular inflammation. TI severity, but not glomerular injury, identified patients at greater risk for renal failure (P = 0.02). A high National Institutes of Health (NIH) chronicity index also identified patients at risk for renal failure. However, when the glomerular and tubulointerstitial subcomponents of the NIH chronicity index were separated in a bivariate model, only tubulointerstitial chronicity provided prognostic information (hazard ratio [HR] 2.2, 95% confidence interval [95% CI] 1.3–3.6; P = 0.002 versus HR 1.0, 95% CI 0.7–1.5; P = 0.97 for glomerular chronicity). Conclusion: TI identifies lupus nephritis patients at greatest risk for progression to renal failure. The immunologic mechanisms underlying TI may provide novel targets for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
New Equations to Estimate GFR in Children with CKD
Schwartz, G. J., Mun[Combining Tilde]oz, A., Schneider, M. F., Mak, R. H., Kaskel, F., Warady, B. A., & Furth, S. L. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008030287 · Cited by 3,777
Cervera, R., Khamashta, M. A., Font, J., Sebastiani, G. D., Gil, A., Lavilla, P., Mejía, J. C., Aydintug, A. O., Chwalinska-Sadowska, H., de Ramón, E., et al. (2003) · Medicine · doi:10.1097/01.md.0000091181.93122.55 · Cited by 1,377
Mortality in systemic lupus erythematosus
Bernatsky, S., Boivin, J. ‐., Joseph, L., Manzi, S., Ginzler, E., Gladman, D. D., Urowitz, M., Fortin, P. R., Petri, M., Barr, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21955 · Cited by 1,181
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
Ginzler, E. M., Dooley, M. A., Aranow, C., Kim, M. Y., Buyon, J., Merrill, J. T., Petri, M., Gilkeson, G. S., Wallace, D. J., Weisman, M. H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043731 · Cited by 1,128
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Appel, G. B., Contreras, G., Dooley, M. A., Ginzler, E. M., Isenberg, D., Jayne, D., Li, L.-S., Mysler, E., Sa[Combining Acute Accent]nchez-Guerrero, J., Solomons, N., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008101028 · Cited by 1,118
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
Nath, K. A. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80312-x · Cited by 974
Prognostic factors in lupus nephritis
Austin, H. A., Muenz, L. R., Joyce, K. M., Antonovych, T. T., Kullick, M. E., Klippel, J. H., Decker, J. L., & Balow, J. E. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90338-8 · Cited by 773
Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data
Austin, H. A., Boumpas, D. T., Vaughan, E. M., & Balow, J. E. (1994) · Kidney International · doi:10.1038/ki.1994.70 · Cited by 407
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y., & Hendriksen, S. M. (2008) · Annals of Internal Medicine · Cited by 394
Chang, A., Henderson, S. G., Brandt, D., Liu, N., Guttikonda, R., Hsieh, C., Kaverina, N., Utset, T. O., Meehan, S. M., Quigg, R. J., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001983 · Cited by 360
Self-citationCyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans
Dooley, M. A., Hogan, S., Jennette, C., Falk, R., & for the Glomerular Disease Collaborative Network (1997) · Kidney International · doi:10.1038/ki.1997.162 · Cited by 341
Long-term follow-up of patients with lupus nephritis
Appel, G. B., Cohen, D. J., Pirani, C. L., Meltzer, J. I., & Estes, D. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90645-0 · Cited by 278
Yu, F., Wu, L.-H., Tan, Y., Li, L.-H., Wang, C.-L., Wang, W.-K., Qu, Z., Chen, M.-H., Gao, J.-J., Li, Z.-Y., et al. (2010) · Kidney International · doi:10.1038/ki.2010.13 · Cited by 249
Lupus nephritis: Correlation of interstitial cells with glomerular function
Alexopoulos, E., Seron, D., Barrie Hartley, R., & Stewart Cameron, J. (1990) · Kidney International · doi:10.1038/ki.1990.14 · Cited by 225
Outcomes in African Americans and Hispanics with lupus nephritis
Contreras, G., Lenz, O., Pardo, V., Borja, E., Cely, C., Iqbal, K., Nahar, N., de La Cuesta, C., Hurtado, A., Fornoni, A., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000243 · Cited by 202
Prognostic determinants in lupus nephritis: a long-term clinicopathologic study
Donadio, J., Hart, G., Bergstralh, E., & Holley, K. (1995) · Lupus · doi:10.1177/096120339500400206 · Cited by 195
Contribution of renal biopsy data in predicting outcome in lupus nephritis: analysis of 116 patients
Nossent, J. C., Henzen-Logmans, S. C., Feltkamp‐Vroom, T. M., Berden, J. H. M., & Swaak, T. J. G. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330708 · Cited by 154
Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis
Steinmetz, O. M., Velden, J., Kneissler, U., Marx, M., Klein, A., Helmchen, U. M., Stahl, R. A. K., & Panzer, U. (2008) · Kidney International · doi:10.1038/ki.2008.191 · Cited by 144
Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates
Boucher, A., Droz, D., Adafer, E., & Noël, L. (1986) · Kidney International · doi:10.1038/ki.1986.105 · Cited by 137
Cook, R. J., Gladman, D. D., Pericak, D., & Urowitz, M. B. (2000) · PubMed · Cited by 131
Henderson, L., Masson, P., Craig, J. C., Flanc, R. S., Roberts, M. A., Strippoli, G. F., & Webster, A. C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002922.pub3 · Cited by 131
The Prognosis of Lupus Nephritis in African-Americans: A Retrospective Analysis
Bakir, A. A., Levy, P. S., & Dunea, G. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80177-6 · Cited by 89
Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis
D’Agati, V. D., Appel, G. B., Estes, D., Knowles, D. M., & Pirani, C. L. (1986) · Kidney International · doi:10.1038/ki.1986.223 · Cited by 86
(1995) · PubMed · Cited by 78
Pathologic changes in the renal tubule in systemic lupus erythematosus
Schwartz, M. M., Fennell, J., & Lewis, E. J. (1982) · Human Pathology · doi:10.1016/s0046-8177(82)80268-2 · Cited by 69
Flanc, R. S., Roberts, M. A., Strippoli, G. F., Chadban, S. J., Kerr, P. G., & Atkins, R. C. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002922.pub2 · Cited by 65
Predominant tubulointerstitial nephritis in a patient with systemic lupus nephritis
Mori, Y., Kishimoto, N., Yamahara, H., Kijima, Y., Nose, A., Uchiyama‐Tanaka, Y., Fukui, M., Kitamura, T., Tokoro, T., Masaki, H., et al. (2005) · Clinical and Experimental Nephrology · doi:10.1007/s10157-004-0338-3 · Cited by 64
Incidence and predictors of renal disease in Chinese patients with systemic lupus erythematosus
Mok, C. C., & Tang, S. S. K. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.04.029 · Cited by 63
Arce-Salinas, C. A., Villa, A. R., Martínez-Rueda, J. O., Muñoz, L., Cardiel, M. H., Alcocer-Varela, J. C., & Alarcón-Segovia, D. (1995) · Lupus · doi:10.1177/096120339500400306 · Cited by 38
Gur, H., Kopolovic, Y., & Gross, D. J. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.8.617 · Cited by 38
Lupus nephritis: clinicopathological study of 162 cases in Thailand.
Parichatikanond, P., Francis, N. D., Malasit, P., et al. (1986) · Journal of Clinical Pathology · doi:10.1136/jcp.39.2.160 · Cited by 30
Lupus Nephritis in African Americans
Lea, J. P. (2002) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200202000-00005 · Cited by 28
Cited by
Kaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., van Vollenhoven, R., Ruiz-Irastorza, G., & Hughes, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.39 · Cited by 1,391
IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE
Wang, S., Wang, J., Kumar, V., Karnell, J. L., Naiman, B., Gross, P. S., Rahman, S., Zerrouki, K., Hanna, R., Morehouse, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03750-7 · Cited by 578
Radhakrishnan, J., & Cattran, D. C. (2012) · Kidney International · doi:10.1038/ki.2012.280 · Cited by 417
the Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Consortium, Der, E., Suryawanshi, H., Morozov, P., Kustagi, M., Goilav, B., Ranabothu, S., Izmirly, P., Clancy, R., Belmont, H. M., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0386-1 · Cited by 403
Chang, A., Henderson, S. G., Brandt, D., Liu, N., Guttikonda, R., Hsieh, C., Kaverina, N., Utset, T. O., Meehan, S. M., Quigg, R. J., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001983 · Cited by 360
Self-citation
Metadata
- Authors
- Hsieh, C., Chang, A., Brandt, D., Guttikonda, R., Utset, T. O., & Clark, M. R.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2011-05-31
- Volume
- 63
- Issue
- 6
- Pages
- 865-874
- ISSN
- 0893-7524 (ISSN-L)
- 2151-464X
- 2151-4658
- OpenAlex
- W1975548815
- Cited by
- 321
- References
- 34
- FWCI
- 9.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.